HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Butenas, S. Articles by Mann, K. G. Search for Related Content PubMed PubMed Citation Articles by Butenas, S. Articles by Mann, K. G. Social Bookmarking                      What's this?

Volume 272, Number 34, Issue of August 22, 1997 pp. 21527-21533
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Evaluation of the Initiation Phase of Blood Coagulation Using Ultrasensitive Assays for Serine Proteases

(Received for publication, May 9, 1997)

From the Department of Biochemistry, Health Science Complex, University of Vermont, Burlington, Vermont 05405

The initiation phase of enzyme generation in a reconstituted model of the tissue factor (TF) pathway to thrombin was evaluated. At 1.25 pM added TF, no thrombin generation was observed in the absence of factor V. The substitution of factor Va for factor V increased the rate of thrombin generation. Factor X activation during the initiation phase was not influenced by the absence of factor VIII or thrombin, leading to the conclusion that initially factor Xa is generated exclusively by the factor VIIa-TF complex. When thrombin was eliminated from the system, no contribution of the factor IXa-factor VIIIa complex to factor X activation was observed during the propagation phase. Similarly, factor V activation was also not observed in the absence of thrombin, indicating that thrombin is the only enzyme responsible for factor V and factor VIII activation. Only subnanomolar amounts of factor VII were activated when prothrombin activation was almost complete. In the absence of coagulation inhibitors, factor XI did not influence thrombin generation initiated by 1.25 pM factor VIIa-TF complex. The termination of factor XIa generation by added hirudin in the factor XI experiment indicates that factor XI activation occurs exclusively by thrombin.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Undas, K. Szuldrzynski, K. E. Brummel-Ziedins, W. Tracz, K. Zmudka, and K. G. Mann Systemic blood coagulation activation in acute coronary syndromes Blood, February 26, 2009; 113(9): 2070 - 2078. [Abstract] [Full Text] [PDF]

				T. Orfeo, K. E. Brummel-Ziedins, M. Gissel, S. Butenas, and K. G. Mann The Nature of the Stable Blood Clot Procoagulant Activities J. Biol. Chem., April 11, 2008; 283(15): 9776 - 9786. [Abstract] [Full Text] [PDF]

				G. Bhattacharjee, J. Ahamed, R. Pawlinski, C. Liu, N. Mackman, W. Ruf, and T. S. Edgington Factor Xa Binding to Annexin 2 Mediates Signal Transduction via Protease-Activated Receptor 1 Circ. Res., February 29, 2008; 102(4): 457 - 464. [Abstract] [Full Text] [PDF]

				J. W. Hammon Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389. [Full Text]

				A. Undas, K. E. Brummel-Ziedins, and K. G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood, March 15, 2007; 109(6): 2285 - 2292. [Abstract] [Full Text] [PDF]

				T. Orfeo, S. Butenas, K. E. Brummel-Ziedins, and K. G. Mann The Tissue Factor Requirement in Blood Coagulation J. Biol. Chem., December 30, 2005; 280(52): 42887 - 42896. [Abstract] [Full Text] [PDF]

				D. Chen, K. Giannopoulos, P. G. Shiels, Z. Webster, J. H. McVey, G. Kemball-Cook, E. Tuddenham, M. Moore, R. Lechler, and A. Dorling Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endothelium Blood, September 1, 2004; 104(5): 1344 - 1349. [Abstract] [Full Text] [PDF]

				S. Butenas, T. Orfeo, M. T. Gissel, K. E. Brummel, and K. G. Mann The Significance of Circulating Factor IXa in Blood J. Biol. Chem., May 28, 2004; 279(22): 22875 - 22882. [Abstract] [Full Text] [PDF]

				T. Orfeo, N. Brufatto, M. E. Nesheim, H. Xu, S. Butenas, and K. G. Mann The Factor V Activation Paradox J. Biol. Chem., May 7, 2004; 279(19): 19580 - 19591. [Abstract] [Full Text] [PDF]

				L. H. Edmunds Jr. and R. W. Colman Extracorporeal Circulation: Thrombosis and Bleeding Card. Surg. Adult, January 1, 2003; 2(2003): 338 - 348. [Full Text]

				K. G. Mann, S. Butenas, and K. Brummel The Dynamics of Thrombin Formation Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 17 - 25. [Abstract] [Full Text] [PDF]

				K. G. Mann and M. Kalafatis Factor V: a combination of Dr Jekyll and Mr Hyde Blood, January 1, 2003; 101(1): 20 - 30. [Full Text] [PDF]

				M. F. Hockin, K. C. Jones, S. J. Everse, and K. G. Mann A Model for the Stoichiometric Regulation of Blood Coagulation J. Biol. Chem., May 17, 2002; 277(21): 18322 - 18333. [Abstract] [Full Text] [PDF]

				S. Butenas, K. E. Brummel, R. F. Branda, S. G. Paradis, and K. G. Mann Mechanism of factor VIIa-dependent coagulation in hemophilia blood Blood, February 1, 2002; 99(3): 923 - 930. [Abstract] [Full Text] [PDF]

				A. Undas, K. Brummel, J. Musial, K. G. Mann, and A. Szczeklik Blood coagulation at the site of microvascular injury: effects of low-dose aspirin Blood, October 15, 2001; 98(8): 2423 - 2431. [Abstract] [Full Text] [PDF]

				A. Undas, K. E. Brummel, J. Musial, K. G. Mann, and A. Szczeklik Simvastatin Depresses Blood Clotting by Inhibiting Activation of Prothrombin, Factor V, and Factor XIII and by Enhancing Factor Va Inactivation Circulation, May 8, 2001; 103(18): 2248 - 2253. [Abstract] [Full Text] [PDF]

				S. Butenas, K. M. Cawthern, C. van't Veer, M. E. DiLorenzo, J. B. Lock, and K. G. Mann Antiplatelet agents in tissue factor-induced blood coagulation Blood, April 15, 2001; 97(8): 2314 - 2322. [Abstract] [Full Text] [PDF]

				C. van 't Veer, N. J. Golden, and K. G. Mann Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa Blood, February 15, 2000; 95(4): 1330 - 1335. [Abstract] [Full Text] [PDF]

				S. Butenas, C. van't Veer, and K. G. Mann "Normal" Thrombin Generation Blood, October 1, 1999; 94(7): 2169 - 2178. [Abstract] [Full Text] [PDF]

				K. E. Brummel, S. Butenas, and K. G. Mann An Integrated Study of Fibrinogen during Blood Coagulation J. Biol. Chem., August 6, 1999; 274(32): 22862 - 22870. [Abstract] [Full Text] [PDF]

				K. M. Cawthern, C. van `t Veer, J. B. Lock, M. E. DiLorenzo, R. F. Branda, and K. G. Mann Blood Coagulation in Hemophilia A and Hemophilia C Blood, June 15, 1998; 91(12): 4581 - 4592. [Abstract] [Full Text] [PDF]